Working… Menu

S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00897091
Recruitment Status : Completed
First Posted : May 12, 2009
Last Update Posted : May 30, 2013
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2007
Actual Study Completion Date : October 2007